(177)Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis

BACKGROUND: An updated systematic review and meta‐analysis of relevant studies to evaluate the effectiveness of prostate‐specific membrane antigen (PSMA)‐targeted endoradiotherapy/radioligand therapy (PRLT) in castration resistant prostate cancer (CRPC). METHODS: A systematic search was performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadaghiani, Mohammad S., Sheikhbahaei, Sara, Werner, Rudolf A., Pienta, Kenneth J., Pomper, Martin G., Gorin, Michael A., Solnes, Lilja B., Rowe, Steven P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311733/
https://www.ncbi.nlm.nih.gov/pubmed/35286735
http://dx.doi.org/10.1002/pros.24325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311733/
https://www.ncbi.nlm.nih.gov/pubmed/35286735
http://dx.doi.org/10.1002/pros.24325

Ejemplares similares